Published : Nov-2020
No. of Pages : 314
1.1 List of Tables
1.2 List of Figures
2.1 Inborn Gene or Chromosome Alterations Overview
3 Products under Development
3.1 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
3.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
3.3 Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
3.4 Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
3.5 Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
4 Inborn Gene or Chromosome Alterations - Pipeline Products under Development by Companies
4.1 Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
4.2 Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
5 Inborn Gene or Chromosome Alterations Companies and Product Overview
6 Inborn Gene or Chromosome Alterations- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Table 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
Table 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
Table 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
Table 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
Table 6: Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
Table 7: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Table 8: Aarhus University Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Cystic Fibrosis Urine Test - Product Status
Table 10: Cystic Fibrosis Urine Test - Product Description
Table 11: AbaStar MDx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Molecular Diagnostic Test - Bipolar Disorder - Product Status
Table 13: Molecular Diagnostic Test - Bipolar Disorder - Product Description
Table 14: Molecular Diagnostic Test - Depression - Product Status
Table 15: Molecular Diagnostic Test - Depression - Product Description
Table 16: Molecular Diagnostic Test - Parkinson's Disease - Product Status
Table 17: Molecular Diagnostic Test - Parkinson's Disease - Product Description
Table 18: Molecular Diagnostic Test - Schizophrenia - Product Status
Table 19: Molecular Diagnostic Test - Schizophrenia - Product Description
Table 20: AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Diagnostic Test - Hereditary Deafness - Product Status
Table 22: Diagnostic Test - Hereditary Deafness - Product Description
Table 23: Agena Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Sensigene Trisomy 21 Laboratory Developed Test - Product Status
Table 25: Sensigene Trisomy 21 Laboratory Developed Test - Product Description
Table 26: Alexion Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: SmartPanel - Product Status
Table 28: SmartPanel - Product Description
Table 29: Allele Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: RAD4CHD Test - Product Status
Table 31: RAD4CHD Test - Product Description
Table 32: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Diagnostic Test - IFN-Beta Resistance - Product Status
Table 34: Diagnostic Test - IFN-Beta Resistance - Product Description
Table 35: Amity University Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Prenatal Screening Kit - Product Status
Table 37: Prenatal Screening Kit - Product Description
Table 38: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 39: PDx Pre-Symptomatic Test - Product Status
Table 40: PDx Pre-Symptomatic Test - Product Description
Table 41: Asuragen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Signature CF Expand - Product Status
Table 43: Signature CF Expand - Product Description
Table 44: Augusta University Pipeline Products & Ongoing Clinical Trials Overview
Table 45: SUMO Gene Test - Type 1 Diabetes - Product Status
Table 46: SUMO Gene Test - Type 1 Diabetes - Product Description
Table 47: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Status
Table 49: DNA Guided Diagnostic Test - Cardiovascular Disease - Product Description
Table 50: DNA Guided Diagnostic Test - Diabetes - Product Status
Table 51: DNA Guided Diagnostic Test - Diabetes - Product Description
Table 52: DNA Guided Diagnostic Test - Obesity - Product Status
Table 53: DNA Guided Diagnostic Test - Obesity - Product Description
Table 54: INFINITI Neural Response Panel - Product Status
List of Figures
Figure 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
Figure 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
Figure 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
Figure 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
Figure 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
